GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Interpace Biosciences Inc (STU:PF42) » Definitions » E10

Interpace Biosciences (STU:PF42) E10 : €-30.04 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Interpace Biosciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Interpace Biosciences's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.101. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-30.04 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 17.30% per year. During the past 5 years, the average E10 Growth Rate was 17.30% per year. During the past 10 years, the average E10 Growth Rate was 11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Interpace Biosciences was 19.40% per year. The lowest was -28.80% per year. And the median was 2.30% per year.

As of today (2024-06-07), Interpace Biosciences's current stock price is €1.23. Interpace Biosciences's E10 for the quarter that ended in Mar. 2024 was €-30.04. Interpace Biosciences's Shiller PE Ratio of today is .


Interpace Biosciences E10 Historical Data

The historical data trend for Interpace Biosciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interpace Biosciences E10 Chart

Interpace Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -56.68 -49.40 -47.82 -22.06 -29.66

Interpace Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.94 -32.36 - -29.66 -30.04

Competitive Comparison of Interpace Biosciences's E10

For the Diagnostics & Research subindustry, Interpace Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Interpace Biosciences's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Interpace Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Interpace Biosciences's Shiller PE Ratio falls into.



Interpace Biosciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Interpace Biosciences's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.101/131.7762*131.7762
=0.101

Current CPI (Mar. 2024) = 131.7762.

Interpace Biosciences Quarterly Data

per share eps CPI Adj_EPS
201406 -13.248 100.560 -17.361
201409 -22.504 100.428 -29.529
201412 -40.550 99.070 -53.937
201503 -24.024 99.621 -31.778
201506 -40.986 100.684 -53.643
201509 -27.621 100.392 -36.256
201512 27.173 99.792 35.882
201603 -24.156 100.470 -31.683
201606 -11.481 101.688 -14.878
201609 -36.798 101.861 -47.605
201612 30.715 101.863 39.735
201703 5.142 102.862 6.587
201706 -5.785 103.349 -7.376
201709 -1.259 104.136 -1.593
201712 -1.605 104.011 -2.033
201803 -0.892 105.290 -1.116
201806 -0.599 106.317 -0.742
201809 -0.943 106.507 -1.167
201812 -1.231 105.998 -1.530
201903 -0.832 107.251 -1.022
201906 -1.230 108.070 -1.500
201909 -1.789 108.329 -2.176
201912 -2.601 108.420 -3.161
202003 -2.154 108.902 -2.606
202006 -1.225 108.767 -1.484
202009 -1.307 109.815 -1.568
202012 -1.652 109.897 -1.981
202103 -0.865 111.754 -1.020
202106 -0.697 114.631 -0.801
202109 -0.723 115.734 -0.823
202112 -0.788 117.630 -0.883
202203 -0.481 121.301 -0.523
202206 -0.880 125.017 -0.928
202209 -3.384 125.227 -3.561
202212 -0.349 125.222 -0.367
202303 0.075 127.348 0.078
202306 0.037 128.729 0.038
202309 0.000 129.860 0.000
202312 0.183 129.419 0.186
202403 0.101 131.776 0.101

Add all the adjusted EPS together and divide 10 will get our e10.


Interpace Biosciences  (STU:PF42) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Interpace Biosciences E10 Related Terms

Thank you for viewing the detailed overview of Interpace Biosciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Interpace Biosciences (STU:PF42) Business Description

Traded in Other Exchanges
Address
300 Interpace Parkway, Morris Corporate Center 1, Building C, Parsippany, NJ, USA, 07054
Interpace Biosciences Inc is engaged in the life sciences industry. It provides molecular diagnostics, bioinformatics, and pathology services for the evaluation of the risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. The company develops and commercializes genomic tests and related first-line assays principally focused on the early detection of patients with indeterminate biopsies and at high risk of cancer using the latest technology. It operates under one segment which is the business of developing and selling diagnostic clinical services.

Interpace Biosciences (STU:PF42) Headlines

No Headlines